Cmpx stock forecast.

Source: YCharts. Management said during the company's 2022 investor day in June last year that it expects long-term annual revenue growth of 20%. Assuming AMD's top line grows at an annual pace of ...Analyst Forecast. According to 4 analysts, the average rating for CMPX stock is "Strong Buy." The 12-month stock price forecast is $9.33, which is an increase …Step 1: Check Ratings History. In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the ...Stock Quote & Chart; Historic Price Lookup; Investment Calculator; IR Resources. Investor FAQs; Email Alerts; Contact IR; Careers; Press Releases; Cingulate In the News; back to top. close search window. Search: search submit button. Home. About Us. Cingulate is a clinical stage biopharmaceutical company focused on the development of innovative new …DVN Stock Forecast: DVN Increased by 110.59% with an Accuracy of 100%; MOS Stock Forecast: MOS Increased by 51.34% with an Accuracy of 100%; Energy Stocks: AI Beats the S&P500 by 50.02% with an Accuracy of 73%; COP Stock Forecast: COP Increased by 69.41% with an Accuracy of 100%; Commodity Futures: AI Beats S&P500 by 61.14%

The ALX Oncology Holdings Inc. stock price fell by -4.02% on the last day (Friday, 24th Nov 2023) from $9.21 to $8.84. During the last trading day the stock fluctuated 10.18% from a day low at $8.79 to a day high of $9.69. The price has risen in 6 of the last 10 days and is up by 12.76% over the past 2 weeks.Based on short-term price targets offered by seven analysts, the average price target for Compass Therapeutics, Inc. comes to $9.33. The forecasts range from a low of $8.00 to a high of $11.00 ... Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...

Their AMPX share price targets range from $10.00 to $14.00. On average, they anticipate the company's stock price to reach $12.33 in the next twelve months. This suggests a possible upside of 173.5% from the stock's current price. View analysts price targets for AMPX or view top-rated stocks among Wall Street analysts.The Mirum Pharmaceuticals, Inc. stock price fell by -2.22% on the last day (Tuesday, 28th Nov 2023) from $32.04 to $31.33. During the last trading day the stock fluctuated 4.28% from a day low at $30.75 to a day high of $32.06. The price has fallen in 6 of the last 10 days but is still up by 2.76% over the past 2 weeks.

View the full NASDAQ Composite Index (COMP.US) index overview including the latest stock market news, data and trading information.Price Target Upside/Downside. According to analysts' consensus price target of $9.33, Compass Therapeutics has a forecasted upside of 465.2% from its current price of $1.65. Amount of Analyst Coverage. Compass Therapeutics has received no research coverage in the past 90 days.BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2023. The consensus estimate for Capital Power’s current full-year earnings is $3.23 per share. Raymond James also issued estimates for Capital Power’s Q2 2024 earnings at $0.89 EPS, Q3 2024 earnings at $1.61 EPS, Q4 2024 earnings at $1.17 EPS and FY2024 earnings at $5.27 EPS. Several other research analysts have also weighed in on the stock.

CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%.

Compound Price Live Data. The live Compound price today is $51.45 USD with a 24-hour trading volume of $77,211,369 USD. We update our COMP to USD price in real-time. Compound is up 1.11% in the last 24 hours. The current CoinMarketCap ranking is #107, with a live market cap of $412,787,173 USD. It has a circulating supply of 8,023,528 …

Stock Price Forecast. The 28 analysts offering 12-month price forecasts for APA Corp (US) have a median target of 48.50, with a high estimate of 65.00 and a low estimate of 34.00. The median ... Compound Price Live Data. The live Compound price today is $51.45 USD with a 24-hour trading volume of $77,211,369 USD. We update our COMP to USD price in real-time. Compound is up 1.11% in the last 24 hours. The current CoinMarketCap ranking is #107, with a live market cap of $412,787,173 USD. It has a circulating supply of 8,023,528 …Get actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Apexigen APGN Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com.BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2023.FCEL Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Fuelcell Energy in the last 3 months. The average price target is $1.65 with a high forecast of $2.00 and a low forecast of $1.00. The average price target represents a 35.25% change from the last price of $1.22.

FCEL Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Fuelcell Energy in the last 3 months. The average price target is $1.65 with a high forecast of $2.00 and a low forecast of $1.00. The average price target represents a 35.25% change from the last price of $1.22.The above table shows the analyst CMPX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$1.77 Safe & Green Development Corp. $1.95. -0.70. -26.42%. COMP | A complete NASDAQ Composite Index index overview by MarketWatch. View stock market news, stock market data and trading information.The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...The Bridgebio Pharma Inc. stock price fell by -1.28% on the last day (Wednesday, 29th Nov 2023) from $28.84 to $28.47. During the last trading day the stock fluctuated 4.69% from a day low at $28.37 to a day high of $29.70. The price has been going up and down for this period, and there has been a -3.43% loss for the last 2 weeks.Source: YCharts. Management said during the company's 2022 investor day in June last year that it expects long-term annual revenue growth of 20%. Assuming AMD's top line grows at an annual pace of ...The Compass Therapeutics, Inc. stock price gained 2.42% on the last trading day (Friday, 1st Dec 2023), rising from $1.65 to $1.69. During the last trading …

Nov 10, 2023 · Website. 2014. 26. Tom Schuetz. https://www.compasstherapeutics.com. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 ... Stock price analysis for Compass Therapeutics, Inc. (CMPX), stock quote, stock research, rsi, macd, support, resistance and most important highlights.

Lastly, it’s important to evaluate a stock by comparing it against others in the same industry. Review the table below to see how Compass Therapeutics Inc. stock stands up against its competitors. Click into any of the below tickers to see their stock grades for value, momentum, quality and EPS revisions. Compass Therapeutics Inc. (CMPX ...SFIX Stock 12 Months Forecast. $3.68. (5.75% Upside) Based on 10 Wall Street analysts offering 12 month price targets for Stitch Fix in the last 3 months. The average price target is $3.68 with a high forecast of $5.00 and a low forecast of $2.50. The average price target represents a 5.75% change from the last price of $3.48. Stock Quote & Chart; Historic Price Lookup; Investment Calculator; IR Resources. Investor FAQs; Email Alerts; Contact IR; Careers; Press Releases; Cingulate In the News; back to top. close search window. Search: search submit button. Home. About Us. Cingulate is a clinical stage biopharmaceutical company focused on the development of innovative new …This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of ...Compass Therapeutics Inc. (CMPX) stock has fallen -6.02% while the S&P 500 is higher by 0.38% as of 3:09 PM on Thursday, May 18. CMPX has fallen -$0.19 from the previous closing price of $3.24 on volume of 185,132 shares. Over the past year the S&P 500 is up 6.40% while CMPX is higher by 23.48%. CMPX lost -$0.36 per share the over …Find the latest Physicians Realty Trust (DOC) stock quote, history, news and other vital information to help you with your stock trading and investing.

Compass Therapeutics, Inc. Common Stock (CMPX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Nov 29, 2023 · Greenlane Holdings, Inc. (NASDAQ:GNLN) released its earnings results on Monday, November, 15th. The company reported ($46.00) earnings per share for the quarter, missing the consensus estimate of ($14.00) by $32.00. The company had revenue of $41.31 million for the quarter, compared to analyst estimates of $40.31 million.

Find the latest Fusion Pharmaceuticals Inc. (FUSN) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 22, 2023 · Their COEP share price targets range from $3.00 to $6.00. On average, they expect the company's stock price to reach $4.33 in the next twelve months. This suggests a possible upside of 270.4% from the stock's current price. View analysts price targets for COEP or view top-rated stocks among Wall Street analysts. CMPX Stock 12 Months Forecast. $10.50. (510.47% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Compass Therapeutics in the last 3 months. The average price target is $10.50 with a high forecast of $11.00 and a low forecast of $10.00. The average price target represents a 510.47% change from the last price of $1.72.According to data compiled by TipRanks on 24 March 2023, the consensus analyst forecast for Amazon stock price was bullish. A total of 37 out of 38 analysts rated the stock as a buy, while one gave it a hold rating. The consensus AMZN stock forecast for the next 12 months stood at $136.86 a share. Meanwhile, the highest Amazon stock …What this means: InvestorsObserver gives Compass Therapeutics Inc. (CMPX) an overall rank of 34, which is below average. Compass Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system. Predicting variations in stock price index has been an important application area of machine learning research. Due to the non-linear and complex nature of the stock market making predictions on stock price index is a challenging and non-trivial task. Deep learning approaches have become an important method in modeling complex relationships in …4 brokers have issued twelve-month target prices for Catalyst Pharmaceuticals' stock. Their CPRX share price targets range from $24.00 to $27.00. On average, they predict the company's stock price to reach $24.75 in the next twelve months. This suggests a possible upside of 67.0% from the stock's current price.Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.In many cases to predict stock price, gold and crude oil have been used as extra indicators [36], in some of the works, 43 technical indicators as input features along with LSTM to forecast price ...Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Compass Minerals International Inc have a median target of 43.50, with a high estimate of 82.00 and a low estimate of 36. ...

Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Typically, the average forecast for the group predicts the S&P 500 climbing by about 10%, which is in line with historical averages. 14h ago The Wall Street JournalThe consensus price target of analysts on Wall Street is $9.17, which implies an increase of 82.01% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $11.00 respectively. As a result, CMPX is trading at a discount of -566.67% off the target high and -384.85% off the low.Instagram:https://instagram. clear secure stockworth of 1943 pennyfree version of dall echeapest gold to buy The consensus price target of analysts on Wall Street is $2.50, which implies an increase of 83.2% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.50 and $2.50 respectively. As a result, VGZ is trading at a discount of -495.24% off the target high and -495.24% off the low.Dec 1, 2023 · Price Target Upside/Downside. According to analysts' consensus price target of $9.33, Compass Therapeutics has a forecasted upside of 465.2% from its current price of $1.65. Amount of Analyst Coverage. Compass Therapeutics has received no research coverage in the past 90 days. byd electric car stockgrocery storage cabinets Nov 29, 2023 · CompX International Inc. (NYSE:CIX) posted its quarterly earnings data on Wednesday, November, 1st. The company reported $0.47 earnings per share for the quarter. The business earned $40.30 million during the quarter. CompX International had a net margin of 13.09% and a trailing twelve-month return on equity of 12.79%. The Bridgebio Pharma Inc. stock price fell by -1.28% on the last day (Wednesday, 29th Nov 2023) from $28.84 to $28.47. During the last trading day the stock fluctuated 4.69% from a day low at $28.37 to a day high of $29.70. The price has been going up and down for this period, and there has been a -3.43% loss for the last 2 weeks. top forex companies Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...SCYX Stock 12 Months Forecast. $11.25. (555.98% Upside) Based on 3 Wall Street analysts offering 12 month price targets for SCYNEXIS in the last 3 months. The average price target is $11.25 with a high forecast of $15.00 and a low forecast of $7.50. The average price target represents a 555.98% change from the last price of $1.71.View NASDAQ COMPOSITE COMPX investment & stock information. Get the latest NASDAQ COMPOSITE COMPX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.